Literature DB >> 23429226

The business case for health-care quality improvement.

Stephen J Swensen1, James A Dilling, Patrick M Mc Carty, Jeffrey W Bolton, Charles M Harper.   

Abstract

The business case for health-care quality improvement is presented. We contend that investment in process improvement is aligned with patients' interests, the organization's reputation, and the engagement of their workforce. Four groups benefit directly from quality improvement: patients, providers, insurers, and employers. There is ample opportunity, even in today's predominantly pay-for-volume (that is, evolving toward value-based purchasing) insurance system, for providers to deliver care that is in the best interest of the patient while improving their financial performance.

Entities:  

Mesh:

Year:  2013        PMID: 23429226     DOI: 10.1097/PTS.0b013e3182753e33

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  12 in total

1.  Relationship between hospital financial performance and publicly reported outcomes.

Authors:  Oanh Kieu Nguyen; Ethan A Halm; Anil N Makam
Journal:  J Hosp Med       Date:  2016-02-29       Impact factor: 2.960

2.  The business case for quality improvement.

Authors:  Hannah Ryan Fischer; Scott Davis Duncan
Journal:  J Perinatol       Date:  2020-03-30       Impact factor: 2.521

3.  Continuous quality improvement at the frontline: One interdisciplinary clinical team's four-year journey after completing a virtual learning program.

Authors:  Claire H Robinson; Amy J Thompto; Elizabeth N Lima; Laura J Damschroder
Journal:  Learn Health Syst       Date:  2022-09-27

4.  Costs of Transforming Established Primary Care Practices to Patient-Centered Medical Homes (PCMHs).

Authors:  Neil S Fleming; Briget da Graca; Gerald O Ogola; Steven D Culler; Jessica Austin; Patrice McConnell; Russell McCorkle; Phil Aponte; Michael Massey; Cliff Fullerton
Journal:  J Am Board Fam Med       Date:  2017 Jul-Aug       Impact factor: 2.657

5.  Infection control best practices in clinical research in resource-limited settings.

Authors:  Catherine Godfrey; Jeffrey T Schouten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

6.  Correlation between hospital finances and quality and safety of patient care.

Authors:  Dean D Akinleye; Louise-Anne McNutt; Victoria Lazariu; Colleen C McLaughlin
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

7.  The LEAP Program: Quality Improvement Training to Address Team Readiness Gaps Identified by Implementation Science Findings.

Authors:  Laura J Damschroder; Nicholas R Yankey; Claire H Robinson; Michelle B Freitag; Jennifer A Burns; Susan D Raffa; Julie C Lowery
Journal:  J Gen Intern Med       Date:  2020-09-08       Impact factor: 5.128

8.  Aligning implementation science with improvement practice: a call to action.

Authors:  Jennifer Leeman; Catherine Rohweder; Matthew Lee; Alison Brenner; Andrea Dwyer; Linda K Ko; Meghan C O'Leary; Grace Ryan; Thuy Vu; Shoba Ramanadhan
Journal:  Implement Sci Commun       Date:  2021-09-08

9.  A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.

Authors:  Catherine Godfrey; Gail Tauscher; Sally Hunsberger; Melissa Austin; Lesley Scott; Jeffrey T Schouten; Anne F Luetkemeyer; Constance Benson; Robert Coombs; Susan Swindells
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

Review 10.  Recommendations for strengthening the role of embedded researchers to accelerate implementation in health systems: Findings from a state-of-the-art (SOTA) conference workgroup.

Authors:  Laura J Damschroder; Andrew J Knighton; Emily Griese; Sarah M Greene; Paula Lozano; Amy M Kilbourne; Diana S M Buist; Karen Crotty; A Rani Elwy; Lee A Fleisher; Ralph Gonzales; Amy G Huebschmann; Heather M Limper; NithyaPriya S Ramalingam; Katherine Wilemon; P Michael Ho; Christian D Helfrichfcr
Journal:  Healthc (Amst)       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.